Stocks Getting Investor’s Attention: OmegaFlex, Inc. (NASDAQ:OFLX), SeaDrill Limited (NYSE:SDRL), Impax Laboratories Inc. (NASDAQ:IPXL), Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM), Rentrak Corporation (NASDAQ:RENT)

On Dec. 18, OmegaFlex, Inc. (NASDAQ:OFLX) announced that a United States District Court in Ohio has dismissed the latest frivolous lawsuit by plaintiffs’ attorneys questioning CSST’s unparalleled safety record. In the most recent case – Schoelwer vs Omega Flex, Inc. – the trial attorneys unsuccessfully attempted to seek class action certification for their lawsuit against the Company. OmegaFlex, Inc. (NASDAQ:OFLX) belongs to Industrial Goods sector. … Continue reading Stocks Getting Investor’s Attention: OmegaFlex, Inc. (NASDAQ:OFLX), SeaDrill Limited (NYSE:SDRL), Impax Laboratories Inc. (NASDAQ:IPXL), Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM), Rentrak Corporation (NASDAQ:RENT)

Shining on Major News : RF Micro Devices (NASDAQ:RFMD), JD.com (NASDAQ:JD), Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM), LRAD (NASDAQ:LRAD), Banco Santander, S.A. (NYSE:SAN),

On Sep 5, TriQuint Semiconductor, Inc. announced the preliminary results of its special meeting of shareholders held earlier this afternoon to approve its agreement and plan of merger and reorganization with RF Micro Devices Inc. (NASDAQ:RFMD) and Rocky Holding, Inc. RF Micro Devices Inc. (NASDAQ:RFMD) belongs to Technology sector. Its net profit margin is 4.20% and weekly performance is -2.47%. On last trading day company … Continue reading Shining on Major News : RF Micro Devices (NASDAQ:RFMD), JD.com (NASDAQ:JD), Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM), LRAD (NASDAQ:LRAD), Banco Santander, S.A. (NYSE:SAN),

Chinese IT services provider 21Vianet Group. Inc (VNET) posted second-quarter net loss to shareholders of RMB 62.2 million or $10.0 million, wider than RMB 42.6 million in the prior year. 21Vianet Group, Inc. (NASDAQ:VNET) belongs to Technology sector. Its net profit margin is -10.10% and weekly performance is -5.25%. On last trading day company shares ended up $28.31. 21Vianet Group, Inc. (NASDAQ:VNET) distance from 50-day … Continue reading Worth Watching Stocks: 21Vianet Group (NASDAQ:VNET), Peregrine Pharmaceuticals (NASDAQ:PPHM), Kemper (NYSE:KMPR), Allegheny (NYSE:ATI), Crown Castle International Corp. (NYSE:CCI)

Gogo Inc (NASDAQ:GOGO) was the recipient of a large growth in short interest in January. As of March 31st, there was short interest totalling 10,866,166 shares, a growth of 22.4% from the March 14th total of 8,875,654 shares. Gogo Inc (NASDAQ:GOGO) stock performance was -7.70% in last session and finished the day at $16.79. Traded volume was 5.92million shares in the last session and the average … Continue reading NASDAQ Losers: Gogo Inc (NASDAQ:GOGO), Galena Biopharma Inc (NASDAQ:GALE), Idera Pharmaceuticals (NASDAQ:IDRA), Peregrine Pharmaceuticals (NASDAQ:PPHM)

Trade-Ideas LLC identified Inovio Pharmaceuticals Inc (NYSEMKT:INO) as a “barbarian at the gate” (strong stocks crossing above resistance with today’s range greater than 200%) candidate. Inovio Pharmaceuticals, Inc. (NYSEMKT:INO), together with its subsidiaries, engages in the discovery and development of synthetic vaccines and immune therapies focusing on cancers and infectious diseases. Currently there are 3 analysts that rate Inovio Pharmaceuticals Inc (NYSEMKT:INO) a buy, no … Continue reading Biotech Gainers: Inovio Pharmaceuticals Inc (NYSEMKT:INO), Northwest Biotherapeutics (NASDAQ:NWBO), Peregrine Pharmaceuticals (NASDAQ:PPHM), Dyax (NASDAQ:DYAX)

Inovio Pharmaceuticals, Inc. (AMEX:INO) entered into an office lease (the “Lease”) with a publicly owned real estate investment trust, located in Plymouth Meeting, Pennsylvania. We expect to occupy the space commencing in the third quarter of 2014. The initial term of the lease is eleven and one-half years. We intend to use the facility for office purposes. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock performance was 3.53% … Continue reading Biotech Most Active Stocks: Inovio Pharmaceuticals (NYSEMKT:INO), Northwest Biotherapeutics (NASDAQ:NWBO), Peregrine Pharmaceuticals (NASDAQ:PPHM), MannKind (NASDAQ:MNKD)